Clinical implication of low estrogen receptor (ER-low) expression in breast cancer
Tomás Reinert, Fanny Cascelli, Cristiano Augusto Andrade de Resende, Aline Coelho Gonçalves, Vania Sanchez Prette Godo, Carlos Henrique Barrios DOI: 10.3389/fendo.2022.1015388 Full link: https://www.frontiersin.org/articles/10.3389/fendo.2022.1015388/full
Oral Lichen Planus and Oral Squamous Cell Carcinoma share key oncogenic signatures
Cristóvão Antunes de Lanna, Beatriz Nascimento Monteiro da Silva, Andreia Cristina de Melo, Martín H Bonamino, Lísia Daltro Borges Alves, Luis Felipe Ribeiro Pinto, Abel Silveira Cardoso, Héliton Spíndola Antunes, Mariana Boroni, Daniel Cohen Goldemberg DOI: 10.1038/s41598-022-24801-6 Full link: https://www.nature.com/articles/s41598-022-24801-6
Barriers in access to oncology drugs – a global crisis
Carlos Barrios, Gilberto de Lima Lopes, Mastura Md Yusof, Fidel Rubagumya, Piotr Rutkowski, Manju Sengar DOI: 10.1038/s41571-022-00700-7 Full link: https://www.nature.com/articles/s41571-022-00700-7
Impact of the COVID-19 Pandemic on Cancer Staging: An Analysis of Patients With Breast Cancer From a Community Practice in Brazil
Cristiano A A Resende, Heloísa M Fernandes Cruz, Matheus Costa E Silva, Rafael D Paes, Rodrigo Dienstmann, Carlos H E Barrios, Aline C Goncalves, Fanny G A Cascelli, Andreza K B A Souto, Leandro C Oliveira, Tomás Reinert, Diocesio A P Andrade, Mauro P Passos , Eduardo C Millen, Felipe Zerwes, Paulo L Moraes, Bruno L Ferrari, Max S Mano DOI: 10.1200/GO.22.00289 Full link: https://ascopubs.org/doi/10.1200/GO.22.00289
Radiotherapy activity in the Covid-19 pandemic: Brazil´s operational national-level study
Fabio Y. Moraes, Andre G. Gouveia , Renato P. Lima, Gustavo A. Viani, Vanessa F. Brassati, Ana C. Hamamura DOI: 10.1016/j.jcpo.2022.100367 Full link: https://www.sciencedirect.com/science/article/pii/S2213538322000467
Looking beyond carboplatin and paclitaxel for the treatment of advanced/recurrent endometrial cancer
Maria Rubinstein, Sherry Shen, Bradley J Monk, David S P Tan, Angélica Nogueira-Rodrigues, Daisuke Aoki, Jalid Sehouli, Vicky Makker DOI: 10.1016/j.ygyno.2022.10.012 Full link: https://linkinghub.elsevier.com/retrieve/pii/S0090825822018893
Radiotherapy activity in the COVID 19 pandemic: Brazil’s operational national-level study
Fabio Y Moraes, Andre G Gouveia, Renato P Lima, Vanessa F Bratti, Ana C Hamamura, Gustavo A Viani DOI: 10.1016/j.jcpo.2022.100367 Full link: https://pubmed.ncbi.nlm.nih.gov/36216270/
Radiotherapy activity in the COVID 19 pandemic: Brazil’s operational national-level study
Fabio Y Moraes, Andre G Gouveia, Renato P Lima, Vanessa F Bratti, Ana C Hamamura, Gustavo A Viani DOI: 10.1016/j.jcpo.2022.100367 Full link: https://pubmed.ncbi.nlm.nih.gov/36216270/
In reply to Li et al. Letter to the editor. “Once daily (OD) versus twice-daily (BID) chemoradiation for limited stage small cell lung cancer (LS-SCLC): A meta-analysis of randomized clinical trials.”
Gustavo A. Viani, Andre G. Gouveia, Fabio Y. Moraes DOI: 10.1016/j.radonc.2022.09.017 Full link: https://doi.org/10.1016/j.radonc.2022.09.017
Moderately hypofractionated radiation therapy for breast cancer: A Brazilian cohort study
Gabriela S M de Siqueira , Samir A Hanna , Larissa F de Moura , Fabiana Accioli Miranda , Heloísa de Andrade Carvalho, Gustavo Nader Marta DOI: 10.1016/j.lana.2022.100323 Full link: https://www.sciencedirect.com/science/article/pii/S2667193X22001405?via%3Dihub